Waverley Pharma Inc (WAVE : TSX-V)
Common Stock
$0.01
CAD
+0.00 (%)
Last updated: 2026-05-28
WAVE
Waverley Pharma Inc
WealthAwesomePerformance
1 Day
+0.00%
1 Week
+0.00%
1 Month
+0.00%
YTD
-60.00%
Key Statistics
Market Cap
$540,000
52W High
$0.04
52W Low
$0.01
P/E Ratio
-
50 Day MA
$0.01
200 Day MA
$0.02
Beta
1.21
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 5/28/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 2,000 |
| 5/25/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 5/20/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 4/17/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 20,000 |
| 4/8/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 10,000 |
| 4/2/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 0 |
| 3/31/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 2,000 |
| 3/23/2026 | $0.02 | $0.02 | $0.02 | $0.02 | $0.02 | 49,000 |
| 3/20/2026 | $0.01 | $0.01 | $0.01 | $0.01 | $0.01 | 18,000 |
| 3/9/2026 | $0.02 | $0.03 | $0.02 | $0.03 | $0.03 | 19,000 |
Analyst Price Targets
Based on analyst covering WAVE
Wall Street analysts forecast WAVE stock price to rise 99900.0% over the next 12 months.
Consensus
No RatingAvg. Target
C$10.00
+99900.0% Upside
Current Price
C$0.01
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on WAVE's historical volatility
30-Day Vol
379.6%
Annualized
90-Day Vol
501.2%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.01
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.01 | C$0.00 โ C$0.03 |
| 60 trading days | C$0.01 | C$0.00 โ C$0.06 |
| 90 trading days | C$0.01 | C$0.00 โ C$0.08 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Waverley Pharma Inc
Waverley Pharma Inc., a biopharmaceutical company, researches, develops, and commercializes oncology therapeutics in the United Kingdom. The company develops poly ADP-ribose polymerase-1 (PARP-1) inhibitors for cancer treatment. It also operates a retail pharmacy in the United States. Waverley Pharma Inc. was founded in 2014 and is headquartered in Winnipeg, Canada.
Financials
- Revenue (TTM)
- $1.25M
- EBITDA
- $-395,644
- Profit Margin
- -50.47%
- ROE (TTM)
- -136.53%
- EPS (Diluted)
- -0.01
- Book Value
- -0.04
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About WAVE
Articles Featuring WAVE.V
Latest articles and analysis covering WAVE.V
